Menu

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Why Myrbetriq?

In this section, you'll learn about:

  • Treating OAB with Myrbetriq
  • How it works
  • Starting a conversation with your doctor
  • Possible side effects

What is Myrbetriq® (mirabegron)?

why myrbetriq for overactive bladder treatment, oab

If you have OAB symptoms of urgency, frequency and leakage, ask your healthcare professional (HCP) if Myrbetriq may be right for you.

Myrbetriq is the #1 prescribed* branded medication for OAB

*Based on 24-month TRx shares for all branded OAB medications, IMS Health National Prescription Audit, March 2018-February 2020.

THIS INFORMATION DOES NOT IMPLY SAFETY OR EFFICACY OF ANY PRODUCT; NO COMPARISONS SHOULD BE MADE.

Myrbetriq is a prescription medicine approved
by the U.S. Food and Drug Administration (FDA).
It is used to treat the OAB symptoms of urgency,
frequency and leakage in adults.

In clinical studies, patients taking Myrbetriq versus those not taking it:

  • had improvement in their OAB symptoms within the first 4 to 8 weeks
  • made fewer trips to the bathroom and had fewer leaks

Your results may vary.

If you have OAB symptoms of urgency, frequency and leakage, ask your healthcare professional (HCP) if Myrbetriq may be right for you.

How Does Myrbetriq Work?

With OAB, the bladder muscle suddenly contracts before the bladder is full. This causes frequent and sudden urges to urinate that may be uncontrollable. These urges can sometimes lead to leakage or accidental wetting.

When taken as directed, it can help relax the smooth muscle that surrounds the bladder and increase the bladder's ability to store urine.

Your doctor may prescribe Myrbetriq if you:

  • Take too many trips to the bathroom
  • Have frequent leaks and accidents
  • Have already tried other treatment options

Watch these videos to learn more

talking to your doctor about overactive bladder, oab

Myrbetriq: How It Works

Noted Urologist Dr. David Staskin
discusses
OAB and Myrbetriq

how myrbetriq works for overactive bladder, oab

How Myrbetriq Works in the Body

Watch an animated explanation of
Myrbetriq at work

Start the Conversation with Your Doctor

Take the OAB Symptoms Quiz

Talking with Your Doctor

If you have symptoms of OAB, the first step is having an open, honest discussion with your doctor. Use this simple tool to help you get started and make the most of your discussion.

1
Answer a few questions

2
Print or save the results

3
Show the results to your doctor

Get Started Now!

1. How many times do you urinate during the day?
2. Do you have to rush to the toilet to urinate?
3. Does urine leak before you can get to the toilet?
4. How much do these symptoms bother you?
Please complete the survey.
Next Start over
Find a specialist to talk to about your OAB symptoms
Powered by

What Are the Possible Side Effects of Myrbetriq?

Do not take Myrbetriq if you have an allergy
to mirabegron or any of the ingredients
in Myrbetriq.

Myrbetriq may cause serious side effects including:

Increased blood pressure:
Myrbetriq may
cause your blood pressure to increase or make
your blood pressure worse if you have a history
of high blood pressure. It is recommended that
your doctor check your blood pressure while
you are taking Myrbetriq.

Inability to empty your bladder
(urinary retention):
Myrbetriq may increase your
chances of not being able to empty your
bladder if you have bladder outlet obstruction
(BOO), or if you are taking other medicines to
treat OAB. Tell your doctor right away if you are
unable to empty your bladder.

Angioedema:
Myrbetriq may cause an allergic
reaction with swelling of the lips, face, tongue,
throat, with or without difficulty breathing. Stop
using Myrbetriq and tell your doctor right away.

Click on the side effect(s) to see the number of patients who were affected (per 100)

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    9.2 out of 100
  • Active Control
    9.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    4.1 out of 100
  • Active Control
    2.5 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    1.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    8.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.7 out of 100
  • Active Control
    1.5 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.1 out of 100
  • Active Control
    2.0 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    5.9 out of 100
  • Active Control
    6.4 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    3.9 out of 100
  • Active Control
    3.1 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    2.7 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.7 out of 100
  • Active Control
    2.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.6 out of 100
  • Active Control
    3.4 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.1 out of 100
  • Active Control
    2.3 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    9.2 out of 100
  • Active Control
    9.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    5.9 out of 100
  • Active Control
    6.4 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    4.1 out of 100
  • Active Control
    2.5 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    3.9 out of 100
  • Active Control
    3.1 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    1.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    2.7 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.8 out of 100
  • Active Control
    8.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.7 out of 100
  • Active Control
    2.6 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.7 out of 100
  • Active Control
    1.5 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.6 out of 100
  • Active Control
    3.4 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.1 out of 100
  • Active Control
    2.0 out of 100

Number of patients who experienced side effect

  • Myrbetriq 50 mg
    2.1 out of 100
  • Active Control
    2.3 out of 100

Tell your doctor if you have any side effect that bothers you or that does not go away or if you have swelling of the face, lips, tongue, or throat, hives, skin rash or itching while taking Myrbetriq. These are not all the possible side effects of Myrbetriq. For more information, ask
your doctor or pharmacist.

Approved for Combination Use

For adults with overactive bladder symptoms of urgency, frequency and leakage, Myrbetriq® (mirabegron) is FDA-approved for use in combination with solifenacin succinate. Ask your doctor if this combination treatment may be right for you.

What is MYRBETRIQ? MYRBETRIQ is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat the following symptoms due to a condition called overactive bladder:

  • Urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • Urgency: a strong need to urinate right away
  • Frequency: urinating often

It is not known if MYRBETRIQ, when used alone or with solifenacin succinate, is safe and effective in children.

How should I take MYRBETRIQ

  • If your doctor prescribes MYRBETRIQ and solifenacin succinate together, you should take 1 MYRBETRIQ tablet and 1 solifenacin tablet at the same time, 1 time a day.
  • You should take MYRBETRIQ with water and swallow the tablet whole.
  • Do not chew, break, or crush the tablet.
  • You can take MYRBETRIQ with or without food.
  • You can take MYRBETRIQ and solifenacin succinate together with or without food.

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include:

  • dry mouth
  • urinary tract infection
  • constipation
  • fast heartbeat

USE OF MYRBETRIQ Myrbetriq® (mirabegron) is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

IMPORTANT SAFETY INFORMATION FOR MYRBETRIQ Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®), or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include dry mouth, urinary tract infection, constipation, and fast heartbeat.

Please refer to the solifenacin succinate Patient Product Information and complete Prescribing Information when taking in combination with Myrbetriq.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Myrbetriq is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

Next Section
What People Are Saying
Prev Section
Living With OAB
Previous:
Living With OAB
Next:
What People Are Saying

Use of Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to WebMD.

Continue Cancel

This website is funded and developed by Astellas Pharma US, Inc. Myrbetriq is a registered trademark of Astellas Pharma Inc.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide